<SEC-DOCUMENT>0000905148-20-000733-index.html : 20200629
<SEC-HEADER>0000905148-20-000733.hdr.sgml : 20200629
<ACCEPTANCE-DATETIME>20200629180515
ACCESSION NUMBER:		0000905148-20-000733
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20200626
FILED AS OF DATE:		20200629
DATE AS OF CHANGE:		20200629

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Namouni Fouad
		CENTRAL INDEX KEY:			0001815851

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39069
		FILM NUMBER:		20997965

	MAIL ADDRESS:	
		STREET 1:		535 BOYLSTON ST., 2ND FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aprea Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001781983
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		535 BOYLSTON STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
		BUSINESS PHONE:		6095104718

	MAIL ADDRESS:	
		STREET 1:		535 BOYLSTON STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4.xml
<TEXT>
Document 1 - file: form4.html

Document 1 - RAW XML: form4.xml

</DOCUMENT>
</SEC-DOCUMENT>